H.C. Wainwright Starts Traws Pharma Inc. (TRAW) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts TRAW Hot Sheet
Price: $0.34 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 56
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 56
Join SI Premium – FREE
H.C. Wainwright initiates coverage on Traws Pharma Inc. (NASDAQ: TRAW) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on Traws Pharma Inc. click here. For more ratings news on Traws Pharma Inc. click here.
Shares of Traws Pharma Inc. closed at $2.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue Airways (JBLU) Misses Q3 EPS by 6c, Misses on Revenue
- Zedge, Inc. (ZDGE) Misses Q4 EPS by 3c
- Shine Minerals discloses unauthorized payments and unapproved financing
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
